{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T13:15:22Z","timestamp":1779196522666,"version":"3.51.4"},"reference-count":11,"publisher":"BMJ","issue":"5","license":[{"start":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T00:00:00Z","timestamp":1779148800000},"content-version":"unspecified","delay-in-days":18,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Medical Research Council Clinical Academic Partnership award","award":["MR\/W030004\/1"],"award-info":[{"award-number":["MR\/W030004\/1"]}]},{"DOI":"10.13039\/100011946","name":"Abbott Diabetes Care","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100011946","id-type":"DOI","asserted-by":"publisher"}]},{"name":"EASD-Novo Nordisk Foundation Diabetes Prize for Excellence"},{"name":"Mylife Diabetes"},{"DOI":"10.13039\/501100018956","name":"NIHR Cambridge Biomedical Research Centre","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100018956","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000361","name":"Diabetes UK","doi-asserted-by":"publisher","award":["24\/0006756"],"award-info":[{"award-number":["24\/0006756"]}],"id":[{"id":"10.13039\/501100000361","id-type":"DOI","asserted-by":"publisher"}]},{"name":"EFSD Novo Nordisk Foundation Future Leaders Award"}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Open"],"accepted":{"date-parts":[[2026,4,10]]},"published-print":{"date-parts":[[2026,5]]},"abstract":"<jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>Type 2 diabetes (T2D) presents a global healthcare burden. Despite widespread use of non-insulin glucose lowering therapies, many individuals still require insulin to achieve recommended target glycated haemoglobin (HbA1c). Insulin injections improve HbA1c but can lead to problematic hypoglycaemia. The objective of this study is to determine whether fully closed-loop insulin delivery improves HbA1c at 26 weeks compared with standard insulin therapy with continuous glucose monitoring (CGM) in adults with T2D.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods and analysis<\/jats:title>\n                    <jats:p>This study adopts an open-label, multinational, randomised, single-period parallel design and aims to randomise 224 adults with T2D to either standard insulin therapy with CGM (control group) or fully closed-loop insulin delivery (intervention group) for a period of 26 weeks. Participants will complete a run-in period of 2\u20133 weeks wearing a masked CGM followed by randomisation to either the control or intervention group. The primary endpoint is the between-group difference in HbA1c at 26 weeks. Key endpoints include time in target glucose range (3.9\u201310.0\u2009mmol\/L), mean sensor glucose, time above range (&gt;10.0\u2009mmol\/L) and non-inferiority for time below target (&lt;3.9\u2009mmol\/L) over the 26-week study period. Secondary outcomes include standard CGM metrics, binary metrics for HbA1c, total daily insulin dose, body mass index, blood pressure, fasted lipid profile, renal function and liver function. Safety will be assessed by the frequency of severe hypoglycaemic episodes and other adverse events. Utility will be assessed by CGM and closed-loop system use. The impact of fully closed-loop will be assessed using validated questionnaires and interviews.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Ethics and dissemination<\/jats:title>\n                    <jats:p>The study has received ethical approval from the East of England Cambridgeshire and Hertfordshire Research Ethics Committee (24\/EE\/0149) in the UK. Ethical approval for non-UK site has been obtained by local Research Ethics Committees.<\/jats:p>\n                    <jats:p>Results will be disseminated by peer-reviewed publications and conference presentations, and findings will be shared with people living with diabetes, healthcare providers and relevant stakeholders.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Trial registration number<\/jats:title>\n                    <jats:p>\n                      <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"clintrialgov\" xlink:href=\"NCT06579404\">NCT06579404<\/jats:ext-link>\n                      .\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/bmjopen-2025-115464","type":"journal-article","created":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T13:00:26Z","timestamp":1779195626000},"page":"e115464","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":0,"title":["Assessing the efficacy, safety and utility of fully closed-loop insulin delivery compared to standard insulin therapy with a continuous glucose monitor in adults with type 2 diabetes (COYOTE study): a randomised parallel study protocol"],"prefix":"10.1136","volume":"16","clinical-trial-number":[{"clinical-trial-number":"nct06579404","registry":"10.18810\/clinical-trials-gov"}],"author":[{"ORCID":"https:\/\/orcid.org\/0009-0005-0640-0632","authenticated-orcid":false,"given":"R","family":"Seese","sequence":"first","affiliation":[{"name":"Institute of Metabolic Science-Metabolic Research Laboratories, University of Cambridge, Cambridge, England, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"CK","family":"Boughton","sequence":"additional","affiliation":[{"name":"Institute of Metabolic Science-Metabolic Research Laboratories, University of Cambridge, Cambridge, England, UK"},{"name":"Wolfson Diabetes and Endocrine Clinic, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"FT","family":"Tseung","sequence":"additional","affiliation":[{"name":"Institute of Metabolic Science-Metabolic Research Laboratories, University of Cambridge, Cambridge, England, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R","family":"Uy","sequence":"additional","affiliation":[{"name":"Institute of Metabolic Science-Metabolic Research Laboratories, University of Cambridge, Cambridge, England, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"ME","family":"Wilinska","sequence":"additional","affiliation":[{"name":"Institute of Metabolic Science-Metabolic Research Laboratories, University of Cambridge, Cambridge, England, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H","family":"Thabit","sequence":"additional","affiliation":[{"name":"Manchester Royal Infirmary, Central Manchester University Hospitals NHS Foundation Trust, Manchester, UK"},{"name":"Faculty of Biology, Medicine and Health, The University of Manchester, Manchester, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-1948-1960","authenticated-orcid":false,"given":"YS","family":"Cheah","sequence":"additional","affiliation":[{"name":"King\u2019s College Hospital, King\u2019s College Hospital NHS Foundation Trust, London, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S","family":"Neupane","sequence":"additional","affiliation":[{"name":"Norwich Medicine School, University of East Anglia, Norwich, UK"},{"name":"Norfolk and Norwich University Hospital, Norfolk and Norwich University Hospitals NHS Foundation Trust, Norwich, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S","family":"Hussain","sequence":"additional","affiliation":[{"name":"Department of Diabetes, School of Cardiovascular, Metabolic Medicine and Sciences, King\u2019s College London, London, UK"},{"name":"Department of Diabetes and Endocrinology, Guy\u2019s & St Thomas\u2019 NHS Foundation Trust, London, UK"},{"name":"Institute of Diabetes, Endocrinology and Obesity, King\u2019s Health Partners, London, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P","family":"Choudhary","sequence":"additional","affiliation":[{"name":"Leicester Diabetes Centre, University Hospitals of Leicester NHS Trust, Leicester, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"EG","family":"Wilmot","sequence":"additional","affiliation":[{"name":"School of Medicine, University of Nottingham, Nottingham, UK"},{"name":"University Hospitals of Derby and Burton NHS Foundation Trust, Derby, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1993-7672","authenticated-orcid":false,"given":"L","family":"Bally","sequence":"additional","affiliation":[{"name":"Inselspital University Hospital Bern, Bern, Switzerland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H","family":"Hanaire","sequence":"additional","affiliation":[{"name":"University of Toulouse, Toulouse, France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7854-4233","authenticated-orcid":false,"given":"JK","family":"Mader","sequence":"additional","affiliation":[{"name":"Medical University of Graz, Graz, Austria"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M","family":"Haluz\u00edk","sequence":"additional","affiliation":[{"name":"Institute for Clinical and Experimental Medicine, Prague, Czech Republic"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0870-4032","authenticated-orcid":false,"given":"D","family":"O\u2019Neal","sequence":"additional","affiliation":[{"name":"Department of Medicine St. Vincent\u2019s Hospital Melbourne, The University of Melbourne, Melbourne, Victoria, Australia"},{"name":"Baker Heart and Diabetes Institute, Melbourne, Victoria, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J","family":"Lawton","sequence":"additional","affiliation":[{"name":"School of Population Health Sciences, The University of Edinburgh Usher Institute, Edinburgh, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D","family":"Rankin","sequence":"additional","affiliation":[{"name":"School of Population Health Sciences, The University of Edinburgh Usher Institute, Edinburgh, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C","family":"Kollman","sequence":"additional","affiliation":[{"name":"The Jaeb Center for Health Research, Tampa, Florida, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6022-862X","authenticated-orcid":false,"given":"G","family":"Dunseath","sequence":"additional","affiliation":[{"name":"Diabetes Research Group, Swansea University, Swansea, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R","family":"Hovorka","sequence":"additional","affiliation":[{"name":"Institute of Metabolic Science-Metabolic Research Laboratories, University of Cambridge, Cambridge, England, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2026,5,19]]},"reference":[{"key":"2026051906001457000_16.5.e115464.1","unstructured":"Diabetes UK . Reverse the trend: reducing type 2 diabetes in young people. London. 2024."},{"key":"2026051906001457000_16.5.e115464.2","unstructured":"International Diabetes Federation . IDF diabetes atlas. Brussels, 2025."},{"key":"2026051906001457000_16.5.e115464.3","doi-asserted-by":"crossref","first-page":"279","DOI":"10.2337\/dc24-1516","article-title":"Intensive Glucose Lowering and Its Effects on Vascular Events and Death According to Age at Diagnosis and Duration of Diabetes: The ADVANCE Trial","volume":"48","author":"Ohkuma","year":"2025","journal-title":"Diabetes Care"},{"key":"2026051906001457000_16.5.e115464.4","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9149(07)00004-5"},{"key":"2026051906001457000_16.5.e115464.5","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinthera.2020.12.015"},{"key":"2026051906001457000_16.5.e115464.6","unstructured":"NHS England Digital . National diabetes audit 2021-22: report 1 \u2013 care processes and treatment targets, detailed analysis report. England and Wales. 2021."},{"key":"2026051906001457000_16.5.e115464.7","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1038\/s41591-022-02144-z","article-title":"Fully automated closed-loop insulin delivery in adults with type 2 diabetes: an open-label, single-center, randomized crossover trial","volume":"29","author":"Daly","year":"2023","journal-title":"Nat Med"},{"key":"2026051906001457000_16.5.e115464.8","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2025-111408","article-title":"Assessing the efficacy, safety and utility of hybrid closed-loop glucose control compared with standard insulin therapy combined with continuous glucose monitoring in young people (\u226516 years) and adults with cystic fibrosis-related diabetes (CL4P-CF study): protocol for an open-label, multicentre, randomised, two-arm and single-period parallel trial","volume":"15","author":"Kadiyala","year":"2025","journal-title":"BMJ Open"},{"key":"2026051906001457000_16.5.e115464.9","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199309303291401"},{"key":"2026051906001457000_16.5.e115464.10","doi-asserted-by":"crossref","first-page":"1801","DOI":"10.1056\/NEJMoa2415948","article-title":"A Randomized Trial of Automated Insulin Delivery in Type 2 Diabetes","volume":"392","author":"Kudva","year":"2025","journal-title":"N Engl J Med"},{"key":"2026051906001457000_16.5.e115464.11","doi-asserted-by":"crossref","first-page":"1778","DOI":"10.2337\/dc24-0623","article-title":"Closed-Loop Insulin Therapy for People With Type 2 Diabetes Treated With an Insulin Pump: A 12-Week Multicenter, Open-Label Randomized, Controlled, Crossover Trial","volume":"47","author":"Borel","year":"2024","journal-title":"Diabetes Care"}],"container-title":["BMJ Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjopen-2025-115464","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T13:00:29Z","timestamp":1779195629000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmjopen.bmj.com\/lookup\/doi\/10.1136\/bmjopen-2025-115464"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":11,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2026,5,19]]},"published-print":{"date-parts":[[2026,5]]}},"alternative-id":["10.1136\/bmjopen-2025-115464"],"URL":"https:\/\/doi.org\/10.1136\/bmjopen-2025-115464","relation":{},"ISSN":["2044-6055","2044-6055"],"issn-type":[{"value":"2044-6055","type":"print"},{"value":"2044-6055","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5]]}}}